The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Of the estimated 38 million Americans diagnosed with diabetes, an overwhelming majority has Type 2. Diabetes is a chronic health condition that affects how the body turns food into energy. It develops ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...

When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending that most people newly diagnosed with type 2 diabetes be offered SGLT2 inhibitors alongside ...